Perinatal Hepatitis B Prevention Program, Supplemental Evaluation Projects (PHBPP-SEP)
Grant Amount: Approximate Current Fiscal Year Funding: $400,000; Approximate Total Project Period Funding: $1,200,000.
CDC announces the availability of Fiscal Year (FY) 2013 funds for cooperative agreements with state or local jurisdictions that have existing Perinatal Hepatitis B Prevention Programs (PHBPP). The purpose of this funding announcement is for Supplemental Evaluation Projects (SEP) to facilitate or enhance the success of current immunization practice to prevent mother-to-child transmission of hepatitis B through assessment of (1) The completeness of screening and reporting hepatitis B infected (hepatitis B surface antigen positive, [HBsAg-positive]) pregnant women for PHBPP case management of their infants, including immunization. (2) The implementation of prenatal evaluation and antiviral treatment for selected HBsAg-positive pregnant women which may impact the hepatitis B virus (HBV) outcomes of infants receiving hepatitis B immunization. (3) Facility-based reporting of universal hepatitis B “birth dose” vaccine coverage according to guidelines of the National Quality Forum, and the reliability of the reports in a sample of facilities.
The goals of this FOA are derived from the HHS Viral Hepatitis Action Plan (available at: http://www.hhs.gov/ash/initiatives/hepatitis), and reflect the Healthy People 2020 immunization and infectious disease objectives to reduce chronic hepatitis B virus infections in infants and young children (perinatal infections), and provide a birth dose of hepatitis B vaccine (0-3 days between birthdate and date of vaccination).
US Department of Health and Human Services Public Health Service Centers for Disease Control and Prevention
American Samoa District of Columbia Federated States of Micronesia Guam Marshall Islands National Northern Mariana Islands Palau Puerto Rico US Virgin Islands
Public Health Departments/Social Services Departments State Agencies
Number of Awards Given
2 to 4 awards
Award Amount Notes
Approximate Current Fiscal Year Funding: $400,000; Approximate Total Project Period Funding: $1,200,000 This amount is an estimate, and is subject to availability of funds. It includes direct and/or indirect costs.
Letter of Intent Date
Application Due Date
Tech Info Management Section DHHS CDC Procurement & Grants Ofc 2920 Brandywine Road, MS E-14 Atlanta, GA 30341 Phone: (770) 488-2700
Trudy V Murphy Project Officer CDC/NCHHSTPDivision of Viral Hepatitis 1600 Clifton Rd, MS-G-37 Atlanta, GA 30333 Phone: (404) 639-8845
Childbirth Health Care Programs/Services Hepatitis Prevention Perinatal Transmission
Infants Pregnant Women
Applicants must download the SF424 application package associated with this funding opportunity from Grants.gov. If access to the Internet is not available or if the applicant encounters difficulty in accessing the forms on-line, contact the HHS/CDC Procurement and Grant Office Technical Information Management Section (PGO TIMS) staff at (770) 488-2700 email:firstname.lastname@example.org Monday-Friday 7:00am – 4:30pm U.S. Eastern Standard Time for further instruction. CDC Telecommunications for the hearing impaired or disabled is available at: TTY 1-888-232-6348.
If the applicant encounters technical difficulties with Grants.gov, the applicant should contact Grants.gov Customer Service. The Grants.gov Contact Center is available 24 hours a day, 7 days a week, with the exception of all Federal Holidays. The Contact Center provides customer service to the applicant community. The extended hours will provide applicants support around the clock, ensuring the best possible customer service is received any time it’s needed. The Grants.gov Support Center can be reached at 1-800-518-4726 or by e-mail at email@example.com. Submissions sent by e-mail, fax, CD’s or thumb drives of applications will not be accepted.
Disclaimer: NPIN provides this information as a public service only. The views and information provided about the materials, funding opportunities, and organizations do not necessarily state or reflect those of the U.S. Department of Health and Human Services, CDC, or NPIN.